Receptor-ligand supplementation via a self-cleaving 2A peptide-based gene therapy promotes CNS axonal transport with functional recovery. (2021)
Attributed to:
Joint Wellcome and MRC Centre, ‘Wellcome Trust – Medical Research Council Cambridge Stem Cell Institute’
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1126/sciadv.abd2590
PubMed Identifier: 33789891
Publication URI: http://europepmc.org/abstract/MED/33789891
Type: Journal Article/Review
Volume: 7
Parent Publication: Science advances
Issue: 14
ISSN: 2375-2548